Connect with us

Hi, what are you looking for?

Latest News

Maryland Rep. Jamie Raskin diagnosed with ‘serious but curable’ cancer

Rep. Jamie Raskin, D-Md., announced on Wednesday that he has been diagnosed with ‘a serious but curable form of cancer,’ called Diffuse Large B Cell Lymphoma.

Raskin, who was the lead impeachment manager for former President Donald Trump’s second impeachment, and is now on the Jan. 6 Committee, made the announcement about his cancer in a press release.

‘After several days of tests, I have been diagnosed with Diffuse Large B Cell Lymphoma, which is a serious but curable form of cancer,’ he said. ‘I am about to embark on a course of chemo-immunotherapy on an outpatient basis at Med Star Georgetown University Hospital and Lombardi Comprehensive Cancer Center. Prognosis for most people in my situation is excellent after four months of treatment.’

Raskin said he expects to be able to continue working as he goes through treatment but was told by his doctors to be cautious and try to reduce unnecessary exposure to COVID-19, the flu, or any other viruses.

The concern is that chemotherapy can make the body’s immune system vulnerable to viruses.

‘I am advised that it also causes hair loss and weight gain,’ Raskin added.

This post appeared first on FOX NEWS

You May Also Like


Inflation appears to be on the decline. The Personal Consumption Expenditures Price Index (PCEPI), which is the Federal Reserve’s preferred measure of inflation, grew...


Artificial Intelligence has been the buzz word in financial markets ever since Microsoft announced its multibillion-dollar investment in ChatGPT (read more). According to Futurum...


“I will make no apologies that we are investing to make America strong. Investing in American innovation, in industries that will define the future,...


Mimiq, Inc is announcing today the launch of their new product, Mimiq Track, at CES as part of their latest product line to operate...

Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2023